Genetic variations in the active efflux pump genes acrA/B and tolC in different drug-induced strains of escherichia coli CVCC 1547

Genetics and Molecular Research

Volumn 12, Issue 3, 2013, Pages 2829-2836

  Hu, G Z ^a   Liu, J H ^a   Pan, Y S ^a   Yuan, L ^a   Wu, H ^a   Chen, Y X ^a  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

AcrA B tolC; Active efflux pump; Genetic variations; MDR

Indexed keywords

ALANINE; AMIKACIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTIOFUR; CEFTRIAXONE; CIPROFLOXACIN; GATIFLOXACIN; ISOLEUCINE; LEVOFLOXACIN; QUINOLONE DERIVATIVE; THREONINE; VALINE;

ACRA GENE; ACRB GENE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CROSS RESISTANCE; DNA SEQUENCE; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC VARIABILITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; SEQUENCE ANALYSIS; TOLC GENE;

AMIKACIN; BACTERIAL OUTER MEMBRANE PROTEINS; CEFTRIAXONE; CIPROFLOXACIN; CODON, NONSENSE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

EID: 84881507232     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.August.8.3     Document Type: Article

References (21)

1. Bailey AM, Webber MA and Piddock LJ (2006). Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli. Antimicrob. Agents Chemother. 50: 1071-1074.
2. Bratu S, Landman D, George A, Salvani J, et al. (2009). Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J. Antimicrob. Chemother. 64: 278-283.
3. Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, et al. (2006). How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103: 12879-12884.
4. Chen S, Cui S, McDermott PF, Zhao S, et al. (2007). Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials. Antimicrob. Agents Chemother. 51: 535-542.
5. Chen SL, Hung CS, Xu J, Reigstad CS, et al. (2006). Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl. Acad. Sci. U. S. A. 103: 5977-5982.
6. CLSI (2009). Performance Standards for Antimicrobial Ausceptibility Testing; 19th Informational Supplement, M100-S19. Clinicial and Laboratory Standards Institute, Wayne.
7. Funatsuki K, Tanaka R, Inagaki S, Konno H, et al. (1997). acrB mutation located at carboxyl-terminal region of gyrase B subunit reduces DNA binding of DNA gyrase. J. Biol. Chem. 272: 13302-13308.
8. Hansen LH, Johannesen E, Burmølle M, Sorensen AH, et al. (2004). Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob. Agents Chemother. 48: 3332-3337.
9. Hooper DC (2001). Emerging mechanisms of fluoroquinolone resistance. Emerg. Infect. Dis. 7: 337-341.
10. Jellen-Ritter AS and Kern WV (2001). Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob. Agents Chemother. 45: 1467-1472.
11. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, et al. (2007). A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
12. Kobayashi N, Nishino K and Yamaguchi A (2001). Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183: 5639-5644.
13. Mao W, Warren MS, Black DS, Satou T, et al. (2002). On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46: 889-901.
14. Perna NT, Plunkett G, III, Burland V, Mau B, et al. (2001). Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529-533.
15. Piddock LJ (2006). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19: 382-402.
16. Poole K (2004). Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10: 12-26.
17. Poole K (2007). Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39: 162-176.
18. Rosenberg EY, Ma D and Nikaido H (2000). AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182: 1754-1756.
19. Schwarz S, Kehrenberg C, Doublet B and Cloeckaert A (2004). Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 28: 519-542.
20. Wang H, Dzink-Fox JL, Chen M and Levy SB (2001). Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45: 1515-1521.
21. Welch RA, Burland V, Plunkett G, III, Redford P, et al. (2002). Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99: 17020-17024.